GCAN
The Greater Cannabis Company, Inc. [GCAN] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GCAN Stock Summary
Top 10 Correlated ETFs
GCAN
Top 10 Correlated Stocks
GCAN
In the News
GCAN Financial details
Company Rating
Sell
Market Cap
482.78K
Income
-192K
Revenue
0
Book val./share
-0
Cash/share
0
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-3.1
Forward P/E
-
PEG
0.56
P/S
-
P/B
-0.94
P/C
-
P/FCF
-6.87
Quick Ratio
0.23
Current Ratio
0.23
Debt / Equity
-0.65
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-77.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-68.19%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.03%
Inst Trans
0.96%
ROA
-96%
ROE
33%
ROC
0.27%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.0E-4-0.0015
52W High
-
52W Low
-
RSI
47.22
Rel Volume
0.69
Avg Volume
3.89M
Volume
2.67M
Perf Week
-14.29%
Perf Month
9.09%
Perf Quarter
0%
Perf Half Y
0%
-
-
-
-
Beta
1.564
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0006
Change
0%
GCAN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | -0.06 | -0.02 | 0 | 0 | 0 | |
| Operating cash flow per share | -0.01 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.01 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.04 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | -0.04 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | -0.04 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0.03 | 0.01 | 0 | 0 | 0 | |
| Market cap | 1.15M | 436K | 1.52M | 323.28K | 649.43K | |
| Enterprise value | 1.79M | 605.92K | 1.77M | 556.68K | 914.01K | |
| P/E ratio | -0.54 | -0.17 | -2.98 | -0.59 | -3.45 | |
| Price to sales ratio | 162.13 | 9.07 | 120.15 | 0 | 0 | |
| POCF ratio | -4.05 | -1.51 | -6.45 | -3.01 | -6.29 | |
| PFCF ratio | -4.05 | -1.39 | -6.45 | -3.01 | -6.29 | |
| P/B Ratio | -0.75 | -1.56 | -3.24 | -0.59 | -0.98 | |
| PTB ratio | -0.75 | -1.56 | -3.24 | -0.59 | -0.98 | |
| EV to sales | 251.26 | 12.61 | 140.07 | 0 | 0 | |
| Enterprise value over EBITDA | -2.37 | -0.57 | -2.47 | -2.39 | -5.37 | |
| EV to operating cash flow | -6.27 | -2.09 | -7.51 | -5.18 | -8.86 | |
| EV to free cash flow | -6.27 | -1.93 | -7.51 | -5.18 | -8.86 | |
| Earnings yield | -1.86 | -5.91 | -0.34 | -1.68 | -0.29 | |
| Free cash flow yield | -0.25 | -0.72 | -0.16 | -0.33 | -0.16 | |
| Debt to equity | -0.43 | -1.01 | -1.34 | -0.92 | -0.65 | |
| Debt to assets | 12.52 | 1.57 | 1.6 | 1.8 | 2.5 | |
| Net debt to EBITDA | -0.84 | -0.16 | -0.35 | -1 | -1.55 | |
| Current ratio | 0.03 | 0.35 | 0.44 | 0.33 | 0.2 | |
| Interest coverage | -1.05 | -0.27 | -1.2 | -1.44 | 13.45 | |
| Income quality | 0.17 | 0.3 | 0.39 | 0.3 | 0.55 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 28.65 | 4.25 | 11.96 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.11 | 0.04 | 0.04 | 0.03 | |
| Capex to operating cash flow | 0 | 0.09 | 0 | 0 | 0 | |
| Capex to revenue | 0 | -0.52 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -5.45 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Graham number | 0.25 | 0.03 | 0 | 0 | 0 | |
| ROIC | 0.77 | -258.6 | -1.82 | 6.45 | 0.76 | |
| Return on tangible assets | -40.79 | -16.15 | -1.35 | -2.01 | -1.13 | |
| Graham Net | -0.05 | 0 | 0 | 0 | 0 | |
| Working capital | -1.55M | -300.21K | -484.48K | -555.25K | -666.65K | |
| Tangible asset value | -1.55M | -300.21K | -484.48K | -555.25K | -666.65K | |
| Net current asset value | -1.55M | -300.21K | -484.48K | -555.25K | -666.65K | |
| Invested capital | -0.43 | -1.01 | -1.34 | -0.92 | -0.65 | |
| Average receivables | 0 | 18.38K | 18.38K | 0 | 0 | |
| Average payables | 17.7K | 12.13K | 9.22K | 13.98K | 11.17K | |
| Average inventory | 0 | -18.38K | -18.38K | 0 | 0 | |
| Days sales outstanding | 0 | 279.2 | 0 | 0 | 0 | |
| Days payables outstanding | 120.35 | 51.18 | 337.6 | 113.99 | 444.86 | |
| Days of inventory on hand | 0 | -278.93 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 1.31 | 0 | 0 | 0 | |
| Payables turnover | 3.03 | 7.13 | 1.08 | 3.2 | 0.82 | |
| Inventory turnover | 0 | -1.31 | 0 | 0 | 0 | |
| ROE | 1.39 | 9.22 | 1.09 | 1 | 0.28 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 402.95K | 512.85K | 402.95K | 613.35K | 680.32K | |
| Enterprise value | 636.36K | 764.73K | 665.64K | 881.25K | 944.89K | |
| P/E ratio | -1.92 | -2.75 | -2.24 | -2.87 | -3.63 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | -21.14 | -27.76 | -37.29 | -14.88 | -20.82 | |
| PFCF ratio | -21.14 | -27.76 | -37.29 | -14.88 | -20.82 | |
| P/B Ratio | -0.74 | -0.87 | -0.64 | -0.94 | -1.03 | |
| PTB ratio | -0.74 | -0.87 | -0.64 | -0.94 | -1.03 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | -15.51 | -20.01 | -16.58 | -17.91 | -22.09 | |
| EV to operating cash flow | -33.38 | -41.39 | -61.6 | -21.38 | -28.92 | |
| EV to free cash flow | -33.38 | -41.39 | -61.6 | -21.38 | -28.92 | |
| Earnings yield | -0.13 | -0.09 | -0.11 | -0.09 | -0.07 | |
| Free cash flow yield | -0.05 | -0.04 | -0.03 | -0.07 | -0.05 | |
| Debt to equity | -0.92 | -0.86 | -0.8 | -0.72 | -0.65 | |
| Debt to assets | 1.8 | 1.93 | 2.02 | 2.27 | 2.5 | |
| Net debt to EBITDA | -5.69 | -6.59 | -6.54 | -5.44 | -6.18 | |
| Current ratio | 0.33 | 0.3 | 0.27 | 0.23 | 0.2 | |
| Interest coverage | -8.23 | -10.96 | -11.38 | -17.02 | -15.54 | |
| Income quality | 0.4 | 0.43 | 0.24 | 0.77 | 0.7 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 1.13 | 0.51 | 0.32 | 0.28 | 0.19 | |
| Return on tangible assets | -0.19 | -0.19 | -0.19 | -0.27 | -0.28 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | -555.25K | -597.07K | -640.86K | -657.04K | -666.65K | |
| Tangible asset value | -555.25K | -597.07K | -640.86K | -657.04K | -666.65K | |
| Net current asset value | -555.25K | -597.07K | -640.86K | -657.04K | -666.65K | |
| Invested capital | -0.92 | -0.86 | -0.8 | -0.72 | -0.65 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 15.27K | 11.12K | 5.67K | 4.34K | 4.72K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 28.11 | 65.63 | 47.33 | 15.64 | 438.77 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 3.2 | 1.37 | 1.9 | 5.75 | 0.21 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.1 | 0.08 | 0.07 | 0.08 | 0.07 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
GCAN Frequently Asked Questions
What is The Greater Cannabis Company, Inc. stock symbol ?
The Greater Cannabis Company, Inc. is a US stock , located in Baltimore of Md and trading under the symbol GCAN
What is The Greater Cannabis Company, Inc. stock quote today ?
The Greater Cannabis Company, Inc. stock price is $0.0006 today.
Is The Greater Cannabis Company, Inc. stock public?
Yes, The Greater Cannabis Company, Inc. is a publicly traded company.
Company Profile
- Volume Average 3.89M
- Market Capitalization 482.78K
- Employee 1
- CEO Mr. Aitan Zacharin
- Headquarters Baltimore,MD,US
- IPO Date 2018-09-18
-
Website
https://www.gcanrx.com 
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
